Ovarian Primordial Follicle Development
卵巢原始卵泡发育
基本信息
- 批准号:7228856
- 负责人:
- 金额:$ 23.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-05 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AgonistApoptosisCell CommunicationCellsConditionDevelopmentDiagnostic ProcedureDiseaseEstrogensEventFeedbackFemaleFemale infertilityFertilityFibroblast Growth FactorFibroblast Growth Factor 2Functional disorderFutureGrowth FactorHormonalHormonesIn VitroKnock-outLaboratory cultureMaintenanceMediatingMenopauseMolecularMutant Strains MiceMutationOocytesOrgan Culture TechniquesOvarianPhysiologicalPlayPremature Ovarian FailurePrimordial FollicleProcessProductionProgesteronePubertyPublic HealthRecruitment ActivityRegulationReproductionResearchResearch PersonnelRoleSomatic CellStagingStem Cell FactorSteroidsTestingTherapeuticTransgenic Organismsbone morphogenic proteindesignfolliculogenesisgranulosa cellhuman diseasein vivoinsightinterestkeratinocyte growth factorleukemia inhibitory factormouse modelparacrinepreventprogramsreceptorresearch studysteroid hormonetheca cell
项目摘要
DESCRIPTION (provided by applicant): The proposed research is directed toward developing a better understanding of the mechanisms that control primordial follicle development. This process is essential for the establishment and maintenance of female reproduction. Primordial follicle development involves the initial event of primordial follicle assembly and the subsequent event of primordial to primary follicle transition. The process involved in primordial follicle assembly is distinct from that of primordial to primary follicle transition and both will be investigated in the proposed research. The manners by which locally produced ovarian substances and hormones regulate these processes are of particular interest. Previous research and preliminary studies have demonstrated that the control of primordial follicle development and subsequent folliculogenesis appears to be mediated by the local production and action of specific paracrine factors involving theca cells, granulosa cells, and the oocyte. Preliminary studies have shown that steroid hormones (i.e. estrogen and progesterone) play a critical role in the onset of primordial follicle assembly. Preliminary studies also demonstrate that primordial to primary follicle transition requires integrated interactions between the oocyte, granulosa cells and precursor theca cells involving kit ligand (KL), basic fibroblast growth factor (bFGF), leukemia inhibitory factor (LIF), keratinocyte growth factor (KGF) and bone morphogenic protein-4 (BMP4). "THE GENERAL HYPOTHESIS TESTED IS THAT HORMONES INFLUENCE THE PARACRINE GROWTH FACTOR MEDIATED INTERACTIONS BETWEEN THE OVARIAN SOMATIC CELLS AND THE OOCYTE TO CONTROL PRIMORDIAL FOLLICLE ASSEMBLY AND DEVELOPMENT". Interactions between hormones and paracrine growth factors provide an efficient mechanism to control primordial follicle development. It is anticipated that abnormalities in these cellular interactions will influence female fertility, menopause onset and promote pathophysiologies such as premature ovarian failure. The experimental approach consists of the following specific aims: 1) Elucidate the hormonal and paracrine growth factor control of primordial follicle assembly. 2) Elucidate the hormonal and growth factor control of the primordial to primary follicle transition. 3) Elucidate the physiological importance of specific factors that mediate primordial follicle development. Completion of these specific aims will extend previous observations and provide insight into the role of growth factor mediated cell-cell interactions in regulating primordial follicle development. The critical developmental periods to be examined include the induction of primordial follicle assembly and the primordial to primary follicle transition. It is anticipated that the specific cell-cell interactions will change between these developmental periods. The differential effects of hormones on growth factors and relevant receptors have a critical role in later stages of follicle development, but remain to be determined in primordial follicle development. Observations are anticipated to provide insight into the molecular and cellular control of primordial follicle development. PUBLIC HEALTH RELEVANCE: The information obtained will be used to understand the onset of puberty and menopause, as well as provide insight into the potential future design of diagnostic procedures and therapeutic treatments for abnormal ovarian conditions such as premature ovarian failure (POF) and forms of female infertility. An example of a future experiment proposed is to determine if mutation(s) exist in any of the repertoire of growth factors and/or receptors established in the current study as potential causal factors for disease states such as premature ovarian failure.
描述(由申请人提供):拟议的研究旨在更好地理解控制原始卵泡发育的机制。这一过程对于女性生殖的建立和维持是必不可少的。原始卵泡发育包括原始卵泡组装的初始事件和随后的原始卵泡向初级卵泡过渡的事件。原始卵泡组装的过程不同于原始卵泡向初级卵泡过渡的过程,两者都将在拟议的研究中进行研究。当地产生的卵巢物质和激素调节这些过程的方式特别令人感兴趣。先前的研究和初步研究表明,原始卵泡发育和随后的卵泡形成的控制似乎是由特定的旁分泌因子的局部产生和作用介导的,这些因子包括卵泡细胞、颗粒细胞和卵母细胞。初步研究表明,类固醇激素(即雌激素和黄体酮)在原始卵泡组装的发生中起着关键作用。初步研究还表明,从原始卵泡到初级卵泡的转变需要卵母细胞、颗粒细胞和前体细胞之间的相互作用,包括kit配体(KL)、碱性成纤维细胞生长因子(bFGF)、白血病抑制因子(LIF)、角化细胞生长因子(KGF)和骨形态发生蛋白-4 (BMP4)。“经检验的一般假设是,激素影响旁分泌生长因子介导的卵巢体细胞与卵母细胞之间的相互作用,以控制原始卵泡的组装和发育”。激素与旁分泌生长因子之间的相互作用为控制原始卵泡发育提供了有效的机制。预计这些细胞相互作用的异常将影响女性的生育能力,更年期的发生,并促进卵巢早衰等病理生理。实验方法包括以下具体目的:1)阐明激素和旁分泌生长因子对原始卵泡组装的控制。2)阐明激素和生长因子对原始卵泡向初级卵泡过渡的控制。3)阐明介导原始卵泡发育的特定因子的生理重要性。完成这些特定目标将扩展先前的观察,并提供对生长因子介导的细胞间相互作用在调节原始卵泡发育中的作用的深入了解。要检查的关键发育时期包括诱导原始卵泡组装和原始卵泡向初级卵泡过渡。预计在这些发育时期,特定的细胞-细胞相互作用将发生变化。激素对生长因子和相关受体的差异作用在卵泡发育后期起关键作用,但在原始卵泡发育中仍有待确定。预计观察结果将提供对原始卵泡发育的分子和细胞控制的见解。公共卫生相关性:获得的信息将用于了解青春期和更年期的开始,以及为卵巢异常状况(如卵巢早衰(POF)和女性不孕症)的诊断程序和治疗方法的潜在未来设计提供见解。提出的一个未来实验的例子是确定突变是否存在于任何生长因子和/或受体的库中,在当前的研究中,作为疾病状态(如卵巢早衰)的潜在因果因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL K SKINNER其他文献
MICHAEL K SKINNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL K SKINNER', 18)}}的其他基金
EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONS
表观遗传跨代内分泌干扰作用
- 批准号:
7434209 - 财政年份:2005
- 资助金额:
$ 23.38万 - 项目类别:
Epigenetic Transgenerational Endocrine Disruptor Actions
表观遗传跨代内分泌干扰物作用
- 批准号:
8696510 - 财政年份:2005
- 资助金额:
$ 23.38万 - 项目类别:
Epigenetic Transgenerational Endocrine Disruptor Actions
表观遗传跨代内分泌干扰物作用
- 批准号:
9247187 - 财政年份:2005
- 资助金额:
$ 23.38万 - 项目类别:
Epigenetic Transgenerational Endocrine Disruptor Actions
表观遗传跨代内分泌干扰物作用
- 批准号:
8845554 - 财政年份:2005
- 资助金额:
$ 23.38万 - 项目类别:
Epigenetic Transgenerational Endocrine Disruptor Actions
表观遗传跨代内分泌干扰物作用
- 批准号:
8461236 - 财政年份:2005
- 资助金额:
$ 23.38万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 23.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 23.38万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 23.38万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




